MétaCan
Menu
Back to cohort
Record W4407285575 · doi:10.1093/jcag/gwae059.196

A196 MATERNAL AND NEONATAL OUTCOMES IN PREGNANT WOMEN WITH IBD TREATED WITH USTEKINUMAB OR RISANKIZUMAB: A CASE SERIES

2025· article· en· W4407285575 on OpenAlexaff
Kenneth K. W. Li, Helia Nabavian, Seth A. Eisen, Katie O’Connor, Velandai Srikanth, Vivian Huang

Bibliographic record

VenueJournal of the Canadian Association of Gastroenterology · 2025
Typearticle
Languageen
FieldMedicine
TopicAutoimmune Bullous Skin Diseases
Canadian institutionsUniversity of Toronto
Fundersnot available
KeywordsUstekinumabMedicineObstetricsSeries (stratigraphy)PregnancyPediatricsInternal medicineDisease

Abstract

fetched live from OpenAlex

Abstract Background Biologics are an important therapy for patients with moderate to severe IBD. These include Ustekinumab (UST) – anti-IL-12/23, and the newer biologic Risankizumab (RIS) – anti-IL23. For UST, the PIANO registry and some cohort studies found no significant difference in maternal/neonatal outcomes compared to controls. However, the EPI-MERES registry found an increase in likelihood of small for gestational age births, and one study reported a slower initial postnatal growth rate for in-utero exposed infants. RIS currently has limited evidence in pregnancy. Aims We present a case series of maternal and neonatal outcomes of UST and RIS treated pregnant patients with IBD. Methods We conducted a single-centre case series including patients treated with UST and RIS at any point during pregnancy enrolled between Jan 1, 2017 and Jul 31, 2024. Data was collected on maternal outcomes including live birth, miscarriage, delivery method, and pregnancy-related complications. Neonatal outcomes included preterm birth, small for gestational age (SGA), large for gestational age (LGA), congenital anomalies, NICU admission, APGAR scores, and neonatal infection. Results There were 23 UST patients – 21 (91.3%) had live births and 2 (8.7%) had miscarriages. Of the 21 that delivered, there were 12 (57.1%) vaginal deliveries, 8 (38.1%) elective c-sections, and 1 (4.8%) emergency c-section due to placental insufficiency. One patient had gestational diabetes, 1 had pre-eclampsia, but there were no preterm premature rupture of membranes or intrauterine growth restrictions (IUGR). Of the 21 neonates, 3 (14.3%) were preterm, 1 (4.8%) was SGA, 3 (14.3%) were LGA, and 1 unknown. There were no congenital anomalies. Five (23.8%) infants were admitted to the NICU after birth and 1 (4.8%) was reported to have a postnatal infection within 3 months. Of the 12 infants with known APGAR scores, 10 had scores ≥7 at 1 minute, and 2 were <7. At 5 minutes, all scores were ≥7. Of the 2 RIS patients, 1 was exposed to RIS throughout the entire pregnancy and the other was given a dose during the 1st and 3rd trimester only. Both pregnancies resulted in live births with 1 vaginal delivery and 1 elective c-section. One neonate was LGA. One had an APGAR score of 8 at 1 minute and 9 at 5 minutes. The other infant scored 9 at 1 minute and the score at 5 minutes was not documented. There were no preterm births, congenital anomalies, or pregnancy-related complications. Conclusions In our case series of UST and RIS exposed pregnancies, there were no significant adverse maternal or neonatal outcomes. Further data is necessary to better characterize the safety of both medications. Funding Agencies None

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.503
Threshold uncertainty score0.998

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.005
GPT teacher head0.216
Teacher spread0.212 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueJournal of the Canadian Association of GastroenterologySame topicAutoimmune Bullous Skin DiseasesFrench-language works237,207